Authors:
LUFTNER D
PRINZ B
FLATH B
AKRIVAKIS C
EUCKER J
WERNECKE K
MERGENTHALER HG
POSSINGER K
Citation: D. Luftner et al., ENHANCED COPING EFFORTS MASK DETERIORATION OF OBJECTIVE PARAMETERS OFQUALITY-OF-LIFE, Psycho-oncology, 7(3), 1998, pp. 1046-1046
Authors:
SPATHSCHWALBE E
ARNOLD R
FLATH B
POSSINGER K
Citation: E. Spathschwalbe et al., RED-CELL APLASIA AND MEGAKARYOCYTIC HYPOPLASIA WITH ELEVATED COUNTS OF CD8-POSITIVE LYMPHOCYTES AFTER RESECTION OF A THYMOMA RESPONDING TO CYCLOSPORINE, Annals of hematology, 76(1), 1998, pp. 51-52
Authors:
LUFTNER D
FLATH B
AKRIVAKIS C
GRUNEWALD R
MERGENTHALER HG
POSSINGER K
Citation: D. Luftner et al., GEMCITABINE FOR PALLIATIVE TREATMENT IN METASTATIC BREAST-CANCER, Journal of cancer research and clinical oncology, 124(10), 1998, pp. 527-531
Authors:
LUFTNER D
FLATH B
AKRIVAKIS C
HANSGUNTHER M
OHNMACHT U
ARNING M
POSSINGER K
Citation: D. Luftner et al., GEMCITABINE PLUS DOSE-ESCALATED EPIRUBICIN IN ADVANCED BREAST-CANCER - RESULTS OF A PHASE-I STUDY, Investigational new drugs, 16(2), 1998, pp. 141-146
Citation: Sm. Abdullah et al., MIXED INFECTION OF HUMAN U-937 CELLS BY 2 DIFFERENT SPECIES OF LEISHMANIA, The American journal of tropical medicine and hygiene, 59(2), 1998, pp. 182-188
Citation: B. Flath et al., SIMPLE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETECTION OF PHENYLPROPIONYLGLYCINE IN URINE AS A DIAGNOSTIC-TOOL IN INHERITED MEDIUM-CHAIN ACYL-COENZYME-A DEHYDROGENASE-DEFICIENCY, Journal of chromatography B. Biomedical sciences and applications, 694(1), 1997, pp. 227-232
Authors:
SCHLENGER L
FLATH B
SINN B
BUDACH V
WURM RE
Citation: L. Schlenger et al., CHROMATIN STRUCTURE IN HUMAN GLIOMA CELL-LINES WITH DIFFERENT RADIOSENSITIVITY, European journal of cancer, 33, 1997, pp. 96-96
Authors:
BEINERT T
HOLLER E
MERGENTHALER HG
DUBIEL M
FLEISCHHACKER M
BRUHN N
FLATH B
VOGELMEIER C
BEHR J
WOLFF C
KOLB HJ
Citation: T. Beinert et al., THE ROLE OF LUNG-FUNCTION MEASUREMENTS BEFORE ALLOGENIC BMT TO ANTICIPATE LONG-TERM LUNG FAILURE, European journal of cancer, 33, 1997, pp. 396-396
Authors:
DINGELDEIN G
FLATH B
SEZER O
LUFTNER D
MERGENTHALER HG
POSSINGER K
Citation: G. Dingeldein et al., CONVENTIONAL-DOSAGE OF ADRIAMYCIN AND PACLITAXEL VS. HIGH-DOSE-CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, MITOXANTRONE AND VP-16 IN THE TREATMENT OF METASTATIC BREAST-CANCER - A RANDOMIZED STUDY, European journal of cancer, 33, 1997, pp. 681-681
Authors:
LUFTNER D
FLATH B
PRINZ B
SCHWEIGERT M
AKRIVAKIS C
MERGENTHALER HG
POSSINGER K
Citation: D. Luftner et al., WEEKLY FRACTIONATED PACLITAXEL IN METASTATIC BREAST-CANCER - DOSE OPTIMIZING STUDY, European journal of cancer, 33, 1997, pp. 694-694
Authors:
SCHULZE K
MERGENTHALER HG
FLATH B
SCHWEIGERT M
AKRIVAKIS K
POSSINGER K
Citation: K. Schulze et al., LIPOSOMAL DAUNORUBICIN IN COMBINATION WITH PACLITAXEL IN METASTATIC BREAST-CANCER - A DOSE-FINDING STUDY, European journal of cancer, 33, 1997, pp. 701-701
Authors:
LUFTNER D
FLATH B
GUNTHER S
AKRIVAKIS C
MERGENTHALER HG
POSSINGER K
Citation: D. Luftner et al., CORRELATION BETWEEN THE URINARY DPD-CROSS-LINKS EXCRETION AND THE COURSE OF BONE METASTASES IN BREAST-CANCER, European journal of cancer, 33, 1997, pp. 709-709
Authors:
SPATHSCHWALBE E
FLATH B
GENVRESSE I
POSSINGER K
Citation: E. Spathschwalbe et al., LOW TOXICITY (TOX) OF A PROLONGED INFUSION OF GEMCITABINE (GEM), European journal of cancer, 33, 1997, pp. 1145-1145
Authors:
LOHMANN RD
WEDEL S
FLATH B
NIKOLAUS S
SCHREIBER S
Citation: Rd. Lohmann et al., LACK OF SPONTANEOUS APOPTOSIS IN NEUTROPHILS FROM PATIENTS WITH HIGHLY-ACTIVE ULCERATIVE-COLITIS, Gastroenterology, 112(4), 1997, pp. 1028-1028
Authors:
KAUFMANN O
FLATH B
SPATHSCHWALBE E
POSSINGER K
DIETEL M
Citation: O. Kaufmann et al., IMMUNOHISTOCHEMICAL DETECTION OF CD5 WITH MONOCLONAL-ANTIBODY 4C7 ON PARAFFIN SECTIONS, American journal of clinical pathology, 108(6), 1997, pp. 669-673
Citation: K. Possinger et al., DIPHOSPHONATES IN TREATMENT PROTOCOLS FOR METASTATIC MAMMARY-CARCINOMA, Geburtshilfe und Frauenheilkunde, 56(7), 1996, pp. 91-94
Citation: K. Possinger et al., THERAPY OBJECTIVES IN PATIENTS WITH METAS TASIZED BREAST-CANCER, Schweizerische medizinische Wochenschrift, 125(27-28), 1995, pp. 1347-1353